Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 13, 2026 (8 months ago)

Amantadine HCl (Amantadine Hydrochloride)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15.

Affected NDC 50268-0069-15

Compare with the code on your package — it is the most precise check available.

Drug: Amantadine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Amantadine HCl
Amantadine Hydrochloride
NDC 50268-0069
100 mg/1 Capsule, Liquid Filled
Oral
AvPAK Rx
Recalling firm
AvKARE
NDC code
50268-069-15
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0341-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Amantadine recalls

See all
Class II · Moderate risk

Amantadine HCl Capsules

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Terminated Labeling / mix-up Apace KY LLC D-1035-2017

Other recalls by AvKARE

All 2026 recalls